NeurAxis Inc.

About NeurAxis Inc.

NeurAxis is focused on providing neuromodulation therapies for chronic and debilitating conditions, particularly targeting pediatric and adolescent populations with disorders of gut-brain interactions (DGBIs). Their mission is to improve lives and minimize suffering by offering innovative, safer patient outcomes through research and targeted therapies.

Products & Services

IB-Stim:A first-to-market, FDA-cleared, drug-free, non-surgical device worn behind the ear, indicated for functional abdominal pain associated with IBS and functional dyspepsia in adolescents (ages 8-21) without serious side effects.

RED:A product with FDA 510(k) clearance for testing and evaluation of patients with chronic constipation.

Specialties

Neuromodulation Therapies Percutaneous Electrical Nerve Field Stimulation (PENFS) Gut-Brain Interaction Disorders (DGBIs) Pediatric and Adolescent Healthcare

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 5000000 MR: - FA: 5.0 million FAN: 5000000	D: 2025-05-22 FD: 2025-05-22	-
2	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 5000000 MR: - FA: $5.0 million FAN: 5000000	D: 2025-05-21 FD: 2025-05-21	-
3	RT: Preferred Stock T: - FT: Preferred Stock	A: 3000000 MR: - FA: $3 million FAN: 3000000	D: 2023-11-14 FD: 2023-11-14	1 investors
4	RT: Initial Public Offering (IPO) T: - FT: Initial Public Offering (IPO)	A: 6592000 MR: - FA: $6,592,000 FAN: 6592000	D: 2023-08-09 FD: 2023-08-09	1 investors
5	RT: IPO T: - FT: IPO	A: 6592000 MR: - FA: approximately $6,592,000 FAN: 6592000	D: 2023-08-09 FD: 2023-08-09	1 investors

Registered Direct Offering Latest

2025-05-22

$5.0M

Registered Direct Offering 2025-05-21

$5.0M

Preferred Stock 2023-11-14

$3.0M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Brian Carrico

President and Chief Executive Officer

T

Timothy Henrichs

Chief Financial Officer

D

Dr. Adrian Miranda

Senior VP of Science & Technology and Chief Medical Officer

D

Dr. Chris Brown

Director of Innovation

D

Dr. Thomas Carrico

Chief Regulatory Officer

D

dvgulik

View 3 more team members with Pro

Unlock Full Team Directory

Recent News

NeurAxis Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised